10-K
XBRL
FORM 10-K
- Company
- Aptose Biosciences Inc.
- Filed
- March 23, 2021
- Period of Report
- December 31, 2020
- Accession Number
- 0001171843-21-002006
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →